Renaissance Capital logo

MRSN News

US IPO Weekly Recap: Blue Apron breaks in a busy week for IPOs

APRN

Eight deals priced this week, raising a combined $740 million. Meal-kit unicorn Blue Apron led the pack along with two banks, four biotechs and an enterprise storage provider. The week also saw one SPAC IPO and one Reg A+ offering. Before this week, the...read more

Early-stage biotech Mersana Therapeutics prices IPO at $15, within the range

Mersana Therapeutics logo

Mersana Therapeutics, an early-stage biotech developing antibody drug conjugate therapies for cancers, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Mersana Therapeutics plans to list on the Nasdaq under the symbol...read more

Cancer biotech Mersana Therapeutics sets terms for $75 million IPO

Mersana Therapeutics logo

Mersana Therapeutics, a clinical-stage biotech developing antibody drug conjugate therapies for cancers, announced terms for its IPO on Friday. The Cambridge, MA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14...read more

US IPO Weekly Recap: Blue Apron delivers its IPO filing

APRN

KBL Merger Corp. IV (KBLMU) raised $100 million in the year's 11th SPAC IPO - the only offering during a short holiday week. However, the biggest news arrived on Thursday when meal kit unicorn Blue Apron filed for a US IPO.  ...read more